Articles by O. Schmitz (5)

Long-term glycaemic control with metformin–sulphonylurea–pioglitazone triple therapy in PROactive (PROactive 17)

A. J. Scheen, M. H. Tan, D. J. Betteridge, K. Birkeland, O. Schmitz and B. Charbonnel

Diabetic Medicine 26 ( 10 ): 1033 - 1039 , 2009

Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population

M. A. Bethel, P. Deedwania, N. S. Levitt, O. Schmitz, A. Huntsman-Labed, R. M. Califf, S. M. Haffner and P. Diem

Diabetic Medicine 26 ( 12 ): 1204 - 1211 , 2009

Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18)

A. J. Scheen, M. H. Tan, D. J. Betteridge, K. Birkeland, O. Schmitz and B. Charbonne

Diabetic Medicine 26 ( 12 ): 1242 - 1249 , 2009

Similarity of pharmacodynamic effects of a single injection of insulin glargine, insulin detemir and NPH insulin on glucose metabolism assessed by 24-h euglycaemic clamp studies in healthy humans

L. P. Sorensen, B. Brock, A. Mengel, J. Rungby, N. Moller, S. Nielsen, A. Volund and O. Schmitz

Diabetic Medicine 27 ( 7 ): 830 - 837 , 2010

Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

T. Vilsboll, B. Brock, H. Perrild, K. Levin, H.-H. Lervang, K. Kolendorf, T. Krarup, O. Schmitz, M. Zdravkovic, T. Le-Thi and S. Madsbad

Diabetic Medicine 25 ( 2 ): 152 - 156 , 2008

Do you have a suggestion for journals

Suggest Journal